Skip to main content
UniHealth

Doctor search

Xiao C Wan, MD

Allergy/Immunology · Menlo Park

NPI 1295099042

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
13
1 carrier
Office
1

Offices

1 location · University Healthcare Alliance · 334 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

13 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wan’s office at (650) 498-6500 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Alignment Health Advantage PPO (PPO)Alignment Health PlanListedOct 3, 2026
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026

California Medical Board record

Licence A135680 · Current

Licensed to practise in California · since 2015 · expires 2028-08-31 · University of Pittsburgh School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$204,505

Medicare paid this office $204,505 for 163 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, omalizumab, 5 mg14$78,504None
Return visit (30+ min)72$11,630$112
New patient visit (45+ min)58$8,773$151
Test for allergy using allergenic extract49$7,920$4
Professional service for preparation and provision of 1 or more antigens16$6,851$15
See all 12 services
Every Original Medicare service billed
Injection, omalizumab, 5 mg14$78,504None
Return visit (30+ min)72$11,630$112
New patient visit (45+ min)58$8,773$151
Test for allergy using allergenic extract49$7,920$4
Professional service for preparation and provision of 1 or more antigens16$6,851$15
Short return visit (20+ min)31$3,147$81
Professional service for multiple injections of allergen11$2,139$11
Injection of drug or substance under skin or into muscle21$1,785$14
Test to measure expiratory airflow and volume36$1,580$27
Test to measure the level of nitric oxide gas35$894$20
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's49$887$15
Test for allergy using allergenic extract injected into skin18$786$9

Who their Medicare patients are

163 Original Medicare patients in 2024. Average age 74 · Women 65% · Health risk score 1.09. Above the middle of the specialty; the typical allergy/ immunology clinician is at 1.

Conditions among them: High blood pressure 48% · Coronary heart disease 25% · Cancer 21% · Diabetes 18% · COPD 14% · Atrial fibrillation 14% · Heart failure 12% · Depression 12% · Chronic kidney disease 11%.

The office billed $1,003,761, Medicare allowed $260,596 and paid $204,505; for 9,300 services of 28 kinds; $151,292 of it was for drugs given in the office and $53,214 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20241639,300741.09$1,003,761$204,505
20231759,609730.99$949,522$203,498
20222819,044720.92$713,946$152,115
20212137,032720.89$330,394$95,807
20201815,070720.92$184,265$69,748
20191724,685730.80$156,861$61,162
20182165,865730.91$185,748$74,174
201732435710.78$15,100$6,779

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 13 services

Original Medicare services billed in 2023
Injection, omalizumab, 5 mg13$60,534None
Return visit (30+ min)85$13,330$111
Test for allergy using allergenic extract51$9,556$4
New patient visit (45+ min)55$8,190$149
Professional service for preparation and provision of 1 or more antigens16$7,092$16
Short return visit (20+ min)29$3,156$81
Long return visit (40+ min)18$3,054$161
New patient visit (60+ min)11$2,236$203
Professional service for multiple injections of allergen12$2,020$11
Test for allergy using allergenic extract injected into skin23$1,485$8
Injection of drug or substance under skin or into muscle23$1,432$14
Test to measure expiratory airflow and volume23$849$27
Test to measure the level of nitric oxide gas15$343$20

2022: 12 services

Original Medicare services billed in 2022
Injection, omalizumab, 5 mg12$52,798None
Return visit (30+ min)175$24,867$90
Professional service for preparation and provision of 1 or more antigens48$11,913$14
Test for allergy using allergenic extract59$11,761$3
New patient visit (45+ min)59$7,806$132
Professional service for multiple injections of allergen65$5,393$9
Test to measure expiratory airflow and volume88$2,454$18
Short return visit (20+ min)29$2,148$69
Test for allergy using allergenic extract injected into skin38$1,635$8
Test to measure the level of nitric oxide gas59$1,133$13
Professional service for single injection of allergen14$1,095$8
Injection of drug or substance under skin or into muscle21$940$13

2021: 9 services

Original Medicare services billed in 2021
Return visit (30+ min)143$29,606$107
Test for allergy using allergenic extract57$16,206$4
Professional service for preparation and provision of 1 or more antigens53$12,608$15
New patient visit (45+ min)63$8,388$133
Professional service for multiple injections of allergen59$7,505$10
Test to measure expiratory airflow and volume114$6,462$27
Short return visit (20+ min)56$5,741$78
Test to measure the level of nitric oxide gas75$2,530$19
Test for allergy using allergenic extract injected into skin52$2,481$8

2020: 9 services

Original Medicare services billed in 2020
Return visit (30+ min)117$17,732$87
Professional service for preparation and provision of 1 or more antigens51$13,530$14
Test for allergy using allergenic extract31$10,054$4
Professional service for multiple injections of allergen60$7,821$9
New patient visit (45+ min)41$5,881$143
Short return visit (20+ min)66$5,287$59
Test to measure expiratory airflow and volume76$3,696$32
Test for allergy using allergenic extract injected into skin27$1,464$8
Test to measure the level of nitric oxide gas41$963$19

2019: 9 services

Original Medicare services billed in 2019
Professional service for preparation and provision of 1 or more antigens56$14,242$14
Return visit (30+ min)69$8,789$91
Test for allergy using allergenic extract29$8,276$4
Short return visit (20+ min)90$7,164$56
Professional service for multiple injections of allergen58$7,083$9
Test to measure expiratory airflow and volume92$5,250$31
New patient visit (45+ min)33$4,390$133
Test for allergy using allergenic extract injected into skin26$1,353$8
Test to measure the level of nitric oxide gas43$1,125$19

2018: 12 services

Original Medicare services billed in 2018
Test for allergy using allergenic extract53$17,128$5
Return visit (30+ min)118$14,609$84
Professional service for preparation and provision of 1 or more antigens34$8,084$13
New patient visit (45+ min)54$6,913$128
Test to measure expiratory airflow and volume142$6,801$30
Short return visit (20+ min)84$5,882$55
Professional service for multiple injections of allergen55$4,868$9
Test for allergy using allergenic extract injected into skin42$2,180$7
Test for allergy using ingested items, initial 2 hours12$1,372$106
Test to measure the level of nitric oxide gas50$1,353$19
New patient visit (30+ min)13$992$76
Test to measure expiratory airflow and volume changes before and after medication administration15$908$57

2017: 3 services

Original Medicare services billed in 2017
Return visit (30+ min)15$1,487$87
Test to measure expiratory airflow and volume21$774$32
Test to measure the level of nitric oxide gas13$233$18

Drugs they prescribed that Part D paid

$328,087

Pharmacies billed $328,087 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 505) in 2024. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 0%.

285 generic and 220 brand-name prescriptions · $328,087 in drug cost · 11 antibiotic prescriptions.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
DupixentNone27$106,219$3,934
Gamunex-CImmune globulin16$40,472$2,530
Trelegy ElliptaNone43$29,406$684
AlvescoNone11$9,400$855
Breo ElliptaNone13$5,082$391
See all 12 drugs
Every Part D drug this clinician prescribed
DupixentNone27$106,219$3,934
Gamunex-CImmune globulin16$40,472$2,530
Trelegy ElliptaNone43$29,406$684
AlvescoNone11$9,400$855
Breo ElliptaNone13$5,082$391
Wixela InhubNone28$2,355$84
EpinephrineNone14$1,493$107
Azelastine-FluticasoneNone14$1,428$102
IpratropiumNone37$1,401$38
AzelastineNone49$1,292$26
Albuterol Sulfate HfaNone30$997$33
MontelukastNone55$750$14

Year by year

Part D prescribing by year
20245051600% (0)44%$328,087
20236461990% (0)None$489,968
20221,183233NoneNone$986,295
20211,046181None37%$730,386
2020956179None37%$334,773
2019713152None37%$208,621
2018624170None36%$164,823
201742220% (0)52%$42,321
201640120% (0)None$394,655
201528559None17%$19,656
2014456594% (18)18%$28,180
2013262607% (17)None$13,885

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 17 drugs

Part D drugs prescribed in 2023
Dupixent18$66,153$3,675
Trelegy Ellipta27$23,768$880
Advair Hfa19$15,389$810
Symbicort32$14,965$468
Breo Ellipta19$9,787$515
Advair Diskus15$6,465$431
Flovent Hfa13$4,873$375
Epinephrine22$4,570$208
Azelastine84$2,856$34
Mometasone Furoate11$1,837$167
Ipratropium46$1,419$31
Montelukast74$1,033$14
Albuterol Sulfate Hfa35$916$26
Fluticasone Propionate36$633$18
Famotidine13$135$10
Omeprazole14$90$6
Prednisone13$48$4

2022: 22 drugs

Part D drugs prescribed in 2022
Takhzyro11$550,431$50,039
Trelegy Ellipta93$77,700$835
Breo Ellipta99$47,344$478
Dupixent13$44,213$3,401
Symbicort43$25,591$595
Spiriva Respimat22$18,688$849
Advair Hfa21$16,056$765
Flovent Hfa38$13,296$350
Serevent Diskus12$9,055$755
Wixela Inhub15$7,168$478
Advair Diskus13$6,881$529
Azelastine168$6,775$40
Ipratropium63$3,360$53
Albuterol Sulfate Hfa68$3,228$47
Montelukast136$2,584$19
Epinephrine12$2,270$189
Levocetirizine Dihydrochloride16$1,125$70
Ventolin Hfa11$977$89
Fluticasone Propionate35$564$16
Amoxicillin-Clavulanate Potass22$301$14
Hydroxyzine19$199$10
Prednisone41$136$3

2021: 22 drugs

Part D drugs prescribed in 2021
FirazyrNone11$388,483$35,317
HizentraImmune globulin13$68,795$5,292
DupixentNone14$45,227$3,231
SymbicortNone45$34,024$756
Breo ElliptaNone63$30,369$482
Trelegy ElliptaNone24$24,911$1,038
Spiriva RespimatNone22$20,284$922
Advair DiskusNone30$17,478$583
Flovent HfaNone35$12,956$370
Advair HfaNone13$9,655$743
Serevent DiskusNone11$9,230$839
Wixela InhubNone21$8,904$424
AzelastineNone138$6,294$46
IpratropiumNone67$3,900$58
MontelukastNone181$3,018$17
Albuterol Sulfate HfaNone49$2,553$52
Fluticasone PropionateNone28$567$20
OmeprazoleNone24$510$21
ClarithromycinNone11$457$42
Amoxicillin-Clavulanate PotassNone16$262$16
HydroxyzineNone18$246$14
PrednisoneNone49$142$3

2020: 19 drugs

Part D drugs prescribed in 2020
HizentraImmune globulin14$80,573$5,755
SymbicortNone56$36,986$660
DupixentNone11$34,501$3,136
Breo ElliptaNone37$22,402$605
Spiriva RespimatNone24$17,383$724
Advair DiskusNone23$13,980$608
Wixela InhubNone21$7,484$356
AzelastineNone139$6,688$48
Flovent HfaNone16$5,616$351
Qvar RedihalerNone11$4,605$419
Albuterol Sulfate HfaNone45$3,127$69
IpratropiumNone36$2,872$80
MontelukastNone154$2,258$15
Levalbuterol Tartrate HfaNone18$1,301$72
HydroxyzineNone46$816$18
Amoxicillin-Clavulanate PotassNone25$748$30
Fluticasone PropionateNone24$734$31
OmeprazoleNone12$247$21
PrednisoneNone54$210$4

2019: 19 drugs

Part D drugs prescribed in 2019
HizentraImmune globulin13$74,057$5,697
SymbicortNone62$33,074$533
Advair DiskusNone17$10,665$627
Breo ElliptaNone14$10,356$740
AzelastineNone80$3,629$45
Wixela InhubNone11$3,542$322
Flovent DiskusNone12$3,041$253
IpratropiumNone23$1,926$84
MontelukastNone111$1,742$16
Ventolin HfaNone21$1,621$77
Levalbuterol Tartrate HfaNone16$1,250$78
Albuterol Sulfate HfaNone14$1,117$80
ClarithromycinNone13$502$39
Fluticasone PropionateNone28$349$12
HydroxyzineNone19$332$17
Amoxicillin-Clavulanate PotassNone21$319$15
LevothyroxineNone16$218$14
MupirocinNone13$135$10
PrednisoneNone29$95$3

2018: 17 drugs

Part D drugs prescribed in 2018
HizentraImmune globulin13$73,496$5,654
SymbicortNone34$18,452$543
Advair DiskusNone12$9,352$779
AzelastineNone88$4,599$52
Flovent HfaNone14$4,008$286
OlopatadineNone24$2,475$103
Ventolin HfaNone30$2,240$75
Proair HfaNone15$1,700$113
IpratropiumNone21$1,582$75
MontelukastNone70$1,316$19
Levalbuterol Tartrate HfaNone11$730$66
HydroxyzineNone15$291$19
Fluticasone PropionateNone23$286$12
Amoxicillin-Clavulanate PotassNone22$264$12
PrednisoneNone39$149$4
MupirocinNone13$136$10
AzithromycinNone13$91$7

2015: 6 drugs

Part D drugs prescribed in 2015
Isosorbide Dinitrate12$736$61
Atorvastatin20$525$26
Insulin12$301$25
Amlodipine Besylate26$169$6
Simvastatin18$126$7
Lisinopril11$92$8

2014: 11 drugs

Part D drugs prescribed in 2014
Lantus15$4,159$277
Atorvastatin22$781$35
Metoprolol14$734$52
Labetalol13$663$51
Losartan11$467$42
Simvastatin22$365$17
Amlodipine Besylate30$342$11
Glipizide11$148$13
Tramadol12$116$10
Lisinopril12$115$10
Hydrochlorothiazide14$80$6

2013: 2 drugs

Part D drugs prescribed in 2013
Amlodipine Besylate12$174$15
Tramadol13$133$10

Money from drug and device companies

$46 in 2025

Industry payments by year
202512None$46
202446None$307
202313None$44
202223None$46
202136None$102
2020412None$375
201945$25$211

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Novartis PharmaceuticalsRhapsido$46
2 payments
  • Meals for Rhapsido · 2025-12-09 · $24
  • Meals for Rhapsido · 2025-12-09 · $22
See all 2 published payments
Every published payment
Novartis PharmaceuticalsMeals · 2025-12-09Rhapsido$24
Novartis PharmaceuticalsMeals · 2025-12-09Rhapsido$22
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $307

Payments by company in 2024
AstraZeneca Pharmaceuticals LPTezspire$125
1 payment
  • Meals for Tezspire · 2024-04-25 · $125
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Lifevest$123
2 payments
  • Meals for Lifevest · 2024-03-17 · $75
  • Meals for Lifevest · 2024-01-11 · $48
GenzymeDupixent$34
2 payments
  • Meals · 2024-09-18 · $18
  • Meals for Dupixent · 2024-05-28 · $16
Takeda Pharmaceuticals U.S.A.Cuvitru$25
1 payment
  • Meals for Cuvitru · 2024-04-03 · $25

2023: $44

Payments by company in 2023
PfizerCibinqo$44
3 payments
  • Education for Cibinqo · 2023-04-07 · $15
  • Education for Cibinqo · 2023-04-06 · $15
  • Meals for Eucrisa · 2023-01-17 · $13

2022: $46

Payments by company in 2022
GlaxoSmithKlineNucala$25
2 payments
  • Meals for Nucala · 2022-04-15 · $12
  • Meals for Nucala · 2022-03-17 · $13
AstraZeneca Pharmaceuticals LPTezspire$21
1 payment
  • Meals for Tezspire · 2022-02-16 · $21

2021: $102

Payments by company in 2021
GlaxoSmithKlineNucala$73
4 payments
  • Meals for Nucala · 2021-07-16 · $12
  • Meals for Nucala · 2021-05-21 · $12
  • Meals for Nucala · 2021-03-18 · $23
  • Meals for Trelegy Ellipta · 2021-01-20 · $26
AstraZeneca Pharmaceuticals LPFasenra$16
1 payment
  • Meals for Fasenra · 2021-04-30 · $16
Horizon Therapeutics plcActimmune$13
1 payment
  • Education for Actimmune · 2021-03-30 · $13

2020: $375

Payments by company in 2020
GlaxoSmithKlineNucala$129
7 payments
  • Meals for Nucala · 2020-10-22 · $15
  • Meals for Nucala · 2020-10-14 · $20
  • Meals for Nucala · 2020-09-04 · $8
  • Meals for Nucala · 2020-06-05 · $9
  • Meals for Trelegy Ellipta · 2020-04-07 · $33
  • Meals for Breo Ellipta · 2020-03-20 · $20
  • Meals for Nucala · 2020-02-07 · $25
GenzymeDupixent$125
1 payment
  • Meals for Dupixent · 2020-01-29 · $125
ALK-AbelloOdactra$75
1 payment
  • Meals for Odactra · 2020-12-08 · $75
AstraZeneca Pharmaceuticals LPBreztri Aerosphere$45
3 payments
  • Meals for Fasenra · 2020-12-12 · $22
  • Education for Breztri Aerosphere · 2020-12-03 · $12
  • Education for Breztri Aerosphere · 2020-10-14 · $12

2019: $211

Payments by company in 2019
ALK-AbelloOdactra$125
1 payment
  • Meals for Odactra · 2019-03-12 · $125
GenzymeDupixent$45
2 payments
  • Meals for Dupixent · 2019-04-11 · $22
  • Meals for Dupixent · 2019-03-11 · $23
CSL BehringHaegarda$25
1 payment
  • Honoraria for Haegarda · 2019-09-10 · $25
Regeneron Healthcare SolutionsDupixent$15
1 payment
  • Meals for Dupixent · 2019-10-10 · $15

Professional record

NPI
1295099042
Licence
CA A135680California A135680: Current · expires 2028-08-31
Trained
University of Pittsburgh School of Medicine, 2012
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207K00000X (207K00000X); Internal medicine (207R00000X)
Mailing address
4050 Moorpark Ave, San Jose, CA, 95117
NPI first listed
2012-06-26
NPI last updated
2024-04-12
NPI record certified
2024-04-12

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 4050 Moorpark Ave, San Jose, CA, 95117